×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
Morningstar
Algernon Pharmaceuticals is the parent company of a private subsidiary called Algernon NeuroScience, that is advancing a psychedelic program...
1 month ago
Algernon Pharmaceuticals Strikes Deal to Advance Ifenprodil in Chronic Cough Treatment
Yahoo Finance
Algernon Pharmaceuticals Strikes Deal to Advance Ifenprodil in Chronic Cough Treatment ... In this article: AGNPF. Vancouver, Canada --News Direct...
1 month ago
Algernon Pharmaceuticals Unveils Stroke Study Breakthrough - TipRanks.com
Tipranks
Algernon Pharmaceuticals (TSE:AGN) has released an update. Algernon Pharmaceuticals, a Canadian drug development firm, is set to present promising Phase 1...
2 weeks ago
Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Update
Defense World
Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) saw a significant growth in short interest during the month of April.
1 week ago
Algernon Pharmaceuticals closes $2M acquisition of its chronic cough research program by Seyltx
Proactive financial news
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has finalized the acquisition of its NP-120 (Ifenprodil) research program by US-based...
1 month ago
Algernon sells Ifenprodil, zooms in on DMT for stroke care
Green Market Report
Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) announced Monday that it will prioritize the development of its intravenous...
1 month ago
Seyltx buys Algernon's Phase II chronic cough therapy
Clinical Trials Arena
Selytx bought the programme for $2m and 20% equity and plans to advance ifenprodil in Phase II trials this year.
1 month ago
Algernon Pharmaceuticals Engages Maxim Group to Explore Spin-Off of its Ifenprodil Phase 2 Chronic Cough Drug ...
Psychedelic Alpha
Ifenprodil represents a novel first-in-class potential treatment for chronic cough and is thought to interfere with central signaling in the...
10 months ago
Stock Market Investment Ideas
Streetwise Reports
Clinical-stage pharmaceuticals firm Algernon Pharmaceuticals Inc. has been issued a U.S. patent for the treatment of three related diseases...
4 months ago
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design - Algernon Pharmaceuticals (OTC:AGN
Benzinga
Canadian clinical-stage biotech company Algernon Pharmaceuticals. AGNPF. announced its plans to move forward with an intravenous (IV)...
1 month ago